NYSE : IFF
$2.17 (2.94%)
| Date | Grading Company | Previous Grade | New Grade | Action |
|---|---|---|---|---|
| 2026-07-01 | Morgan Stanley | Overweight | Overweight | Maintain |
| 2026-06-30 | Argus Research | Buy | Buy | Maintain |
| 2026-06-24 | Citigroup | Buy | Buy | Maintain |
| 2026-05-08 | Barclays | Overweight | Overweight | Maintain |
| 2026-05-07 | Citigroup | Buy | Buy | Maintain |
| 2026-05-07 | JP Morgan | Overweight | Overweight | Maintain |
| 2026-05-07 | Oppenheimer | Outperform | Outperform | Maintain |
| 2026-04-22 | Oppenheimer | Outperform | Outperform | Maintain |
| 2026-04-14 | Barclays | Overweight | Overweight | Maintain |
| 2026-04-13 | Citigroup | Buy | Buy | Maintain |
| 2026-04-09 | UBS | Neutral | Neutral | Maintain |
| 2026-02-17 | Barclays | Overweight | Overweight | Maintain |
| 2026-02-17 | Mizuho | Outperform | Outperform | Maintain |
| 2026-02-13 | Wells Fargo | Overweight | Overweight | Maintain |
| 2026-02-13 | Citigroup | Buy | Buy | Maintain |
| 2026-02-13 | Oppenheimer | Perform | Outperform | Upgrade |
| 2026-02-12 | Mizuho | Outperform | Outperform | Maintain |
| 2026-01-22 | Argus Research | Buy | Buy | Maintain |
| 2026-01-21 | Citigroup | Buy | Buy | Maintain |
| 2026-01-12 | UBS | Neutral | Neutral | Maintain |